These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1727816

  • 1. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
    Vuillez JP, Peltier P, Caravel JP, Chetanneau A, Saccavini JC, Chatal JF.
    J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
    [Abstract] [Full Text] [Related]

  • 2. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
    Barbet J, Peltier P, Bardet S, Vuillez JP, Bachelot I, Denet S, Olivier P, Leccia F, Corcuff B, Huglo D, Proye C, Rouvier E, Meyer P, Chatal JF.
    J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
    [Abstract] [Full Text] [Related]

  • 3. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B, Bischof-Delaloye A, Buchegger F, von Fliedner V, Grob JP, Volant JC, Pettavel J, Mach JP.
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [Abstract] [Full Text] [Related]

  • 4. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
    Reiners C, Eilles C, Spiegel W, Becker W, Börner W.
    Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
    [Abstract] [Full Text] [Related]

  • 5. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
    Vuillez JP, Moro D, Brambilla E, Brichon PY, Ferretti G, Saccavini JC, Brambilla C.
    Eur J Cancer; 1994 Dec; 30A(8):1089-92. PubMed ID: 7654435
    [Abstract] [Full Text] [Related]

  • 6. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
    Behr TM, Gratz S, Markus PM, Dunn RM, Hüfner M, Schauer A, Fischer M, Munz DL, Becker H, Becker W.
    Cancer; 1997 Dec 15; 80(12 Suppl):2436-57. PubMed ID: 9406695
    [Abstract] [Full Text] [Related]

  • 7. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
    Sandrock D, Blossey HC, Steinroeder M, Munz DL.
    Henry Ford Hosp Med J; 1989 Dec 15; 37(3-4):173-4. PubMed ID: 2576957
    [Abstract] [Full Text] [Related]

  • 8. Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
    Peltier P, Curtet C, Chatal JF, Le Doussal JM, Daniel G, Aillet G, Gruaz-Guyon A, Barbet J, Delaage M.
    J Nucl Med; 1993 Aug 15; 34(8):1267-73. PubMed ID: 8326383
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin and somatostatin analogues in medullary thyroid carcinoma.
    O'Byrne KJ, O'Hare N, Sweeney E, Freyne PJ, Cullen MJ.
    Nucl Med Commun; 1996 Sep 15; 17(9):810-6. PubMed ID: 8895910
    [Abstract] [Full Text] [Related]

  • 10. Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5.
    Buccheri G, Biggi A, Ferrigno D, D'Angeli B, Vassallo G, Leone A, Taviani M, Comino A.
    Cancer; 1992 Aug 15; 70(4):749-59. PubMed ID: 1643607
    [Abstract] [Full Text] [Related]

  • 11. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.
    O'Byrne KJ, Hamilton D, Robinson I, Sweeney E, Freyne PJ, Cullen MJ.
    Nucl Med Commun; 1992 Mar 15; 13(3):142-8. PubMed ID: 1557212
    [Abstract] [Full Text] [Related]

  • 12. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
    Obradovic V, Artiko V, Petrovic M, Stefanovic B, Krivokapic Z, Zuvela M, Stojkovic M, Stefanovic B, Milovanovic A, Vlajkovic M.
    Hepatogastroenterology; 2006 Mar 15; 53(70):526-30. PubMed ID: 16995454
    [Abstract] [Full Text] [Related]

  • 13. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.
    Siccardi AG, Buraggi GL, Callegaro L, Colella AC, De Filippi PG, Galli G, Mariani G, Masi R, Palumbo R, Riva P.
    Cancer Res; 1989 Jun 01; 49(11):3095-103. PubMed ID: 2655889
    [Abstract] [Full Text] [Related]

  • 14. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM, Goldenberg H, Sharkey RM, Higginbotham-Ford E, Lee RE, Swayne LC, Burger KA, Tsai D, Horowitz JA, Hall TC.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [Abstract] [Full Text] [Related]

  • 15. Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.
    Magnani P, Paganelli G, Songini C, Samuel A, Sudati F, Siccardi AG, Fazio F.
    Br J Cancer; 1996 Sep 01; 74(5):825-31. PubMed ID: 8795589
    [Abstract] [Full Text] [Related]

  • 16. Early immunoscintigraphic localisation of a mediastinal tumour with indium 111-DTPA CEA-specific F(ab')2 monoclonal antibody fragments (BW 431/31) using second tracer isocontour technique.
    Frohn J, Baum RP, Happ J, Falk S, Riemann HE, Hör G.
    Eur J Nucl Med; 1990 Sep 01; 17(1-2):91-3. PubMed ID: 2083548
    [Abstract] [Full Text] [Related]

  • 17. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
    Riva P, Paganelli G, Callegaro L, Bartoli MG, Turci D, Benini S, Deleide G, Scassellati GA, Viale G, Siccardi AG.
    Nucl Med Commun; 1988 Aug 01; 9(8):577-89. PubMed ID: 3173916
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.
    Edington HD, Watson CG, Levine G, Tauxe WN, Yousem SA, Unger M, Kowal CD.
    Surgery; 1988 Dec 01; 104(6):1004-10. PubMed ID: 3194829
    [Abstract] [Full Text] [Related]

  • 19. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
    Vuillez JP, Moro D, Brichon PY, Rouvier E, Brambilla E, Barbet J, Peltier P, Meyer P, Sarrazin R, Brambilla C.
    J Nucl Med; 1997 Apr 01; 38(4):507-11. PubMed ID: 9098191
    [Abstract] [Full Text] [Related]

  • 20. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
    Chetanneau A, Baum RP, Lehur PA, Liehn JC, Perkins AC, Bares R, Bourguet P, Herry JY, Saccavini JC, Chatal JF.
    Eur J Nucl Med; 1990 Apr 01; 17(5):223-9. PubMed ID: 2083556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.